
### [NCIT:C4989](http://purl.obolibrary.org/obo/NCIT_C4989)
**Label:** Childhood Leukemia

**Subclasses:** [NCIT:C7968](http://purl.obolibrary.org/obo/NCIT_C7968) (Childhood Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C3168](http://purl.obolibrary.org/obo/NCIT_C3168) (Childhood Acute Lymphoblastic Leukemia), [NCIT:C7784](http://purl.obolibrary.org/obo/NCIT_C7784) (Recurrent Childhood Acute Lymphoblastic Leukemia), [NCIT:C7940](http://purl.obolibrary.org/obo/NCIT_C7940) (Childhood Acute Monoblastic and Monocytic Leukemia), [NCIT:C9068](http://purl.obolibrary.org/obo/NCIT_C9068) (Recurrent Childhood Acute Myeloid Leukemia), [NCIT:C122624](http://purl.obolibrary.org/obo/NCIT_C122624) (Refractory Childhood Acute Lymphoblastic Leukemia), [NCIT:C122603](http://purl.obolibrary.org/obo/NCIT_C122603) (Infant Leukemia), [NCIT:C122625](http://purl.obolibrary.org/obo/NCIT_C122625) (Childhood Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C122725](http://purl.obolibrary.org/obo/NCIT_C122725) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C122726](http://purl.obolibrary.org/obo/NCIT_C122726) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7), [NCIT:C122621](http://purl.obolibrary.org/obo/NCIT_C122621) (Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement), [NCIT:C68659](http://purl.obolibrary.org/obo/NCIT_C68659) (Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C132101](http://purl.obolibrary.org/obo/NCIT_C132101) (Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10), [NCIT:C7953](http://purl.obolibrary.org/obo/NCIT_C7953) (Childhood T Acute Lymphoblastic Leukemia), [NCIT:C7952](http://purl.obolibrary.org/obo/NCIT_C7952) (Childhood Burkitt Leukemia), [NCIT:C8304](http://purl.obolibrary.org/obo/NCIT_C8304) (Childhood Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C7971](http://purl.obolibrary.org/obo/NCIT_C7971) (Childhood Acute Basophilic Leukemia), [NCIT:C122617](http://purl.obolibrary.org/obo/NCIT_C122617) (Infant Acute Lymphoblastic Leukemia with MLL Rearrangement), [NCIT:C7970](http://purl.obolibrary.org/obo/NCIT_C7970) (Childhood Acute Myelomonocytic Leukemia), [NCIT:C9158](http://purl.obolibrary.org/obo/NCIT_C9158) (Childhood Acute Myeloid Leukemia without Maturation), [NCIT:C7972](http://purl.obolibrary.org/obo/NCIT_C7972) (Childhood Acute Megakaryoblastic Leukemia), [NCIT:C122614](http://purl.obolibrary.org/obo/NCIT_C122614) (Infant Acute Lymphoblastic Leukemia), [NCIT:C9163](http://purl.obolibrary.org/obo/NCIT_C9163) (Childhood Acute Monocytic Leukemia), [NCIT:C9164](http://purl.obolibrary.org/obo/NCIT_C9164) (Childhood Acute Erythroid Leukemia), [NCIT:C9381](http://purl.obolibrary.org/obo/NCIT_C9381) (Childhood Acute Myeloid Leukemia with Maturation), [NCIT:C9140](http://purl.obolibrary.org/obo/NCIT_C9140) (Childhood B Acute Lymphoblastic Leukemia), [NCIT:C9162](http://purl.obolibrary.org/obo/NCIT_C9162) (Childhood Acute Monoblastic Leukemia), [NCIT:C9160](http://purl.obolibrary.org/obo/NCIT_C9160) (Childhood Acute Myeloid Leukemia), [NCIT:C126111](http://purl.obolibrary.org/obo/NCIT_C126111) (Infant Acute Biphenotypic Leukemia), [NCIT:C126110](http://purl.obolibrary.org/obo/NCIT_C126110) (Infant Acute Undifferentiated Leukemia), [NCIT:C131875](http://purl.obolibrary.org/obo/NCIT_C131875) (Recurrent Childhood T Acute Lymphoblastic Leukemia), [NCIT:C122690](http://purl.obolibrary.org/obo/NCIT_C122690) (Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6), [NCIT:C126112](http://purl.obolibrary.org/obo/NCIT_C126112) (Infant T Acute Lymphoblastic Leukemia), 

**Class expressions from DL-Learner:**

- Thing 51.96%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 43.69%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 43.69%


